[Prooxidative characteristics of plasma from the psoriatic patients based on malonic dialdehyde level].
The values of malonic dialdehyde (MDA) were studied in 152 patients with different forms of psoriasis during the pathological process. The level of MDA was found to depend on the severity and extent of the process and on the presence of complications. Higher and persistent changes in MDA levels were observed in patients with complicated and disseminated forms of the disease. The authors show it possible to clinically use the determination of MDA levels to evaluate the prooxidative processes in psoriatic patients for diagnostic and prognostic purposes.